AM

Alvira Mohd Ayaz Bagwan

Active Director Director DIN 11198077
DIN 11198077 First appointment Jul 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Alvira Mohd Ayaz Bagwan

Data last updated:

Alvira Mohd Ayaz Bagwan is a Director at Vitabliss Healthcare Private Limited (since 2025). The company operates in Healthcare.

DIN 11198077
Primary Designation Director
Industry Healthcare
First Appointment 17 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vitabliss Healthcare Private Limited U86900PN2025PTC243969
Director17 Jul 20252025Active

Board colleagues of Alvira Mohd Ayaz Bagwan

NameDINCompanyDesignation
Arbaaz Ahmed Sherwani10601793Vitabliss Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vitabliss Healthcare Private Limited
Premium access

Shareholding and investment profile for Alvira Mohd Ayaz Bagwan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alvira Mohd Ayaz Bagwan

Alvira Mohd Ayaz Bagwan currently holds 1 directorship: Vitabliss Healthcare Private Limited (Director, since 17 Jul 2025).

Alvira Mohd Ayaz Bagwan was first appointed on 17 Jul 2025 as Director at Vitabliss Healthcare Private Limited.

The current boards of Alvira Mohd Ayaz Bagwan's companies include Arbaaz Ahmed Sherwani (Vitabliss Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available